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Protein stabilityLin28 is a small RNA-binding protein that plays an important role in regulating developmental timing, stem cell
reprogramming, and oncogenesis. However, the signiﬁcance of the effect of post-translational modiﬁcations on
Lin28 activity is not fully understood. In this study, we demonstrated that PCAF directly interactedwith and acet-
ylated Lin28. We also showed that the acetylation of Lin28 can be speciﬁcally reversed by the deacetylase SIRT1.
These ﬁndings suggest that the PCAF/SIRT1 balance plays an important role in regulating Lin28 activity. Further-
more, we found that the cold shock domain of Lin28 is the major target of PCAF-mediated acetylation, which
leads to a severe reduction in the Lin28 protein levels and an increase in the level ofmature let-7a. This study pro-
vides the ﬁrst demonstration that post-translational modiﬁcation regulates Lin28 activity during let-7a biogene-
sis and sheds light on the regulation of Lin28 in ES cells and carcinogenesis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The RNA-binding protein Lin28 was ﬁrst characterized in the nema-
tode Caenorhabditis elegans as an important regulator of developmental
timing and as a stage-speciﬁc protein required for cell fate determina-
tion during larval development [1–3]. Lin28 is a well-conserved protein
that is found in multiple species and has been demonstrated to play an
important role in stem cell reprogramming [4]. In mammals, Lin28 is
expressed both in embryonic stem (ES) cells and during early embryo-
genesis, but its expression is restricted to speciﬁc tissues during late
embryogenesis and in adult life [5]. Additionally, Lin28 is one compo-
nent of the cocktail of factors that was successfully used to drive adult
human ﬁbroblasts to become induced pluripotent stem (iPS) cells [4].
Lin28 is a small, 209-amino-acid protein that is composed of an N-
terminal cold shock domain (CSD) and a C-terminal CCHC domain,
which contains two CCHC-type zinc ﬁngers, separated by a short basic
linker region (BLR) [6]. The CSD domain is implicated in the binding of
Lin28 to the terminal loop, and the CCHC-zinc ﬁngers dimerize around
the conserved GGAG motif of let-7-family microRNA precursors, which
blocks their processing into mature microRNAs [7,8]. Let-7 is a tumor
suppressor that functions to repress certain critical oncogenic factors
in cancer cells [9,10]; therefore, in the context of its inhibition of let-7
biogenesis, Lin28 is considered an oncogene [11–15]. Accordingly,g 100005, China. Tel.: +86 10
ng), yfshen@imicams.ac.cnaberrant Lin28 expressionmay contribute to thedevelopmentof aggres-
sive and poorly differentiated tumors [14].
Over the last two decades, it has become clear that post-translational
modiﬁcations such as the acetylation of lysine residues can alter the ac-
tivity and stability of target proteins [16–18]. It is therefore interesting
to determinewhether this is also true for the Lin28-mediated regulation
of let-7a in mammalian cells. PCAF is a well-characterized acetyltrans-
ferase that catalyzes the acetylation of histones and a number of other
nuclear proteins [19–21]. In this study, we demonstrated that PCAF di-
rectly interactswith and acetylates Lin28 and that this could be reversed
by direct interaction with SIRT1. Furthermore, acetylated Lin28 was
found to be unstable, and this is likely due to a Lin28 protein degrada-
tion pathway. Our data demonstrate for the ﬁrst time that the acetyla-
tion and destabilization of Lin28 directly determine the maturation of
let-7a in the RNA-induced silencing complex in cells.
2. Material and methods
2.1. Reagents, antibodies, and plasmids
Trichostatin A (TSA), nicotinamide (NAM), nicotinamide adenine di-
nucleotide (NAD), cycloheximide (CHX), acetyl CoA, and MG132 were
purchased from Sigma.
Antibodies against FLAG-M2 (F2426) and FLAG (F3165) were from
Sigma. Antibodies against Lin28 (sc-54030), Myc (sc-789), and Lamin
B (sc-6216) were from Santa Cruz Biotech. Anti-acetyl lysine (9441)
was from Cell Signaling. Anti-GAPDH (MAB374) was from Chemicon.
Anti-SIRT1 (07-131) was from Millipore.
The open reading frame of mouse lin28 (Genbank Accession NM_
145833) was cloned into pcDNA6-FLAG, pCMV-3tag7-Myc, and pGEX-
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in CCHC ZF domain) and two deletions, FLAG-Lin28-CSD and FLAG-
Lin28-CCHC, were constructed as described [6]. pCX-FLAG-PCAF was a
gift from Dr. Hua Lu (Oregon Health & Science University). pGEX-
PCAF-HAT2 (amino acids 352–658) was from Dr. Marian Martínez-
Balbás (Institute de Biologia Molecular de Barcelona). pCX-FLAG-
PCAF-ΔHAT2, expressing PCAF with a deletion of amino acids
608–623, was provided by Qi-wei Zhai (Institute Nutritional Sciences,
CAS, China). Myc-SIRT1 and Myc-SIRT1H363Y were provided by
Yong-sheng Chang (Peking Union Medical College, Beijing). pGEX-
SIRT1, encoding GST-tagged SIRT1 (amino acids 193–747), was provid-
ed by Wen-ji Dong (Peking Union Medical College, Beijing). For the
SIRT1 knock-down experiments, oligonucleotides for shRNA were gen-
erated by cloning an 18-base sequence from the sirt1 gene (5′-GCACAG
ATCCTCGAACAA-3′) into the pBabe-U6 vector.
2.2. Site-directed mutagenesis
Eukaryotic expression plasmids of the Lin28 proteins containing
amino acid mutations (K to A) were generated by site-directed muta-
genesis of the pcDNA6-Lin28 using the QuikChange® II Site-Directed
Mutagenesis Kit (Stratagene).
2.3. Cell cultures, transfection, and treatment
All of the cell culture media and supplements were obtained from
HyClone. HEK293T cells were maintained in RPMI 1640 supplemented
with 10% fetal calf serum. P19 embryonic carcinoma cells were main-
tained in α-MEM supplemented with 10% fetal calf serum. Cells were
transfected using the VigoFect reagent (Vigorous) according to the
manufacturer's instructions. TSA treatment was carried out using a con-
centration of 300 nM for 12 h, NAM treatment was at 5 mM for 12 h,
MG132was at 25 μMfor 8 h, and CHXwas at 400 μg/ml for the indicated
times.
2.4. Immunoﬂuorescence
HEK293T cells were cultured on poly-lysine-coated coverslips and
ﬁxed in 4% paraformaldehyde for 10 min at room temperature. Cells
were then permeabilized with 0.25% Triton X-100 for 10 min and
blocked with 1% BSA for 1 h at 37 °C. Cells were incubated overnight
at 4 °C with a 1:1000 dilution of anti-FLAG antibody and a 1:50 dilution
of anti-Myc antibody. Following incubation, cells were washed three
times with PBS and incubated for 1 h at room temperature with the ap-
propriate ﬂuorophore-conjugated secondary antibodies. The coverslips
were stained with DAPI and then mounted and observed using a laser
scanning confocal microscope.
2.5. Cell fractionation
HEK293T cells transfectedwith expression plasmidswere harvested
with trypsin-EDTA and resuspended in buffer A (10 mMHEPES, pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.34 M sucrose, 10% glycerol, 1 mM DTT,
1 mM PMSF, 1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 300 nM TSA, and
5 mM NAM). After incubation on ice for 10 min, NP-40 was added to a
ﬁnal concentration of 0.3%, and the cell suspensions were immediately
vortexed for 15 s. The tubes were then centrifuged at maximum speed
(16,000 ×g) for 10 min at 4 °C, and the supernatants were stored as cy-
toplasmic extracts (CEs). Nuclear pellets that were obtained as above
were then lysed in 500 μl lysis buffer (50 mM Tris–HCl, pH 7.4,
150 mM NaCl, 1 mM EDTA, 0.5% Triton-X100, 1 mM DTT, 1 mM PMSF,
1 μg/ml Aprotinin, 1 μg/ml Leupeptin, 300 nM TSA and 5 mM NAM)
for 30 min with gentle rotation. Lysates were centrifuged at maximum
speed (16,000 ×g) for 15 min at 4 °C, and the supernatants were stored
as nuclear extracts (NEs) containing primarily soluble nuclear material.2.6. Immunoprecipitation, GST pull-downassays, and immunoblot analyses
Cells were cultured in 10-cm dishes and harvested in 800 μl of lysis
buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5%
Triton-X100, 1 mM DTT, 1 mM PMSF, 1 μg/ml Aprotinin, and 1 μg/ml
Leupeptin). Cell lysates were rotated at 4 °C for 30 min, and the super-
natant was collected by centrifugation. For immunoprecipitation, cell
lysates were incubated overnight with anti-FLAG M2 beads at 4 °C.
After being washed three times in TBS (50 mM Tris–HCl, 150 mM
NaCl, pH 7.4), the beads were boiled in SDS-PAGE loading buffer for
western blotting using the indicated antibodies. For the pull-down as-
says, each 20 μg of GST-Lin28 or GST-PCAF (in a protein concentration
of 0.5 μg/μl) was incubated overnight with the indicated cell lysates at
4 °C. After being washed three times in PBS, the beads were boiled in
SDS-PAGE loading buffer for western blotting.
The quantity of the FLAG-Lin28 protein was estimated using ImageJ
software. Thebands on the scanned digital images ofwestern blotswere
drawn with a freehand tool after subtracting background, and integrat-
ed intensity values of bands were obtained and normalized to their
respective loading controls.
2.7. In vitro acetyltransferase assay and in vitro deacetylase assay
Recombinant GST-Lin28, GST-PCAF-HAT2, and GST-SIRT1 were
expressed in Escherichia coli BL21 cells and puriﬁed using glutathione
beads (Amersham Biosciences). For the in vitro acetyltransferase assays,
1 μg of GST-PCAF-HAT2 and 5 μg of either GST or GST-Lin28 were incu-
bated in 25 μl of acetyltransferase assay buffer (50 mM Tris, pH 8, 10%
glycerol, 10 mM butyric acid, 0.1 mM EDTA, 1 mM DTT, and 1 mM
PMSF) with or without 20 μM acetyl CoA or 3H-acetyl CoA at 30 °C for
1 h. The reaction products were separated via 10% SDS-PAGE and ana-
lyzed by western blot using an anti-acetyl lysine antibody or detected
by autoﬂuorography. For the in vitro deacetylase assays, GST-Lin28
that had been acetylated in vitro using GST-PCAF-HAT2 was incubated
with puriﬁed GST-SIRT1 at 30 °C for 1 h. The incubation buffer
contained 50 mM Tris–HCl, pH 9, 50 mM NaCl, 4 mM MgCl2, 0.5 mM
DTT, 0.2 mM PMSF, 0.02% NP-40, and 5% glycerol. NAD was added to
the reaction at a ﬁnal concentration of 50 μM. NAMwas added to the re-
action at a ﬁnal concentration of 5 mM. The reaction mixtures were re-
solved via SDS-PAGE and analyzed by western blot using an anti-acetyl
lysine antibody.
2.8. Measuring protein stability
HEK293T cells transfected with FLAG-Lin28 with or without PCAF
were treated with NAM or DMSO. Thirty hours post-transfection, the
cells were treated with CHX (400 μg/ml) for indicated times. The cells
were then harvested and lysed in 200 μl lysis buffer. Equal amounts of
each sample were separated by SDS-PAGE and analyzed by western
blot using anti-FLAG and anti-GAPDH antibodies.
2.9. RNA isolation and quantitative real-time RT-PCR analysis (qRT-PCR)
Total RNAwas extractedwith the Trizol reagent (Invitrogen) accord-
ing to themanufacturer's instructions. cDNAwas synthesized from 1 μg
of total RNA using a Reverse transcription kit (Invitrogen). Quantitative
real-time PCRwas performed using the ExTaqMix kit (Takara), and the
primer sequences used are listed below (F: forward; R: reverse; RT: re-
verse transcription). Relative expression levels were normalized against
internal standards using the comparative CT method recommended
by the instrument producer. The experiments were repeated at least
three times, with statistical analyses conducted for each individual ex-
perimental set. All values in the experiments were expressed as the
means ± S.D. Lin28, F: GGGTTCGGCTTCCTGTCTA; R: GCATGTTCTTCC
CTTTTGG; β-actin, F: ATCGTCCACCGCAAATGCTTCTA; R: AGCCATGCCA
ATCTCATCTTGTT; pri-let-7a, RT: TAGGAAAGACAGTAGATTGTATAGT;
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ATAGT; pre-let-7a, RT: TAGGAAAGACAGTAGATTGTATAGT; F: AGGTAG
TAGGTTGTATAGTTTTAGG; R: TAGGAAAGACAGTAGATTGTATAGT; ma-
ture let-7a, RT: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATA
CGACAACTA; F: GCCGCTGAGGTAGTAGGTTGTA; R: GTGCAGGGTCCGAG
GT. Primers for U6 as the control, F: CTCGCTTCGGCAGCACA; R: AACGCT
TCACGAATTTGCGT. RT comparison of pri- and pre-let-7a: AAAATATGGA
ACGCTTCACGAATTTG; RT comparison of mature let-7a: GTCGTATCCAGT
GCAGGGTCCGAGGTATTCGCACTGGATACGACAAAAATATG.
2.10. Dual luciferase assay
Dual luciferase assays were performed as previously described
[11], with minor modiﬁcations. A binding sequence for the let-7a
miRNA was inserted into the 3′UTR of the pGL3-promoter ﬁreﬂy
luciferase vector (Promega). HEK293T cells grown in 24-well platesFig. 1. PCAF interacts with Lin28. (A) Effect of PCAF on the expression of Lin28. HEK293T cells w
Lin28 and PCAF detected by anti-FLAG and anti-Myc antibodies, respectively. GAPDH: protein lo
ing loading controls is shown in the lower panel. Each bar represents themean value± S.D. from
with (+) the indicated constructs. IP: anti-FLAGM2beads, IB: anti-Myc or FLAG antibody for bo
PCAF (D) was incubated with lysates from HEK293T cells ectopically expressing FLAG-PCAF (C
tibody. Total GST, GST-Lin28 and GST-PCAF were detected by fast green staining. (E) Schemati
shows the GST pull-down assay to identify the interaction of PCAF with the Lin28 truncations
ectopically expressing FLAG-PCAF. The GST pull-down products were immunoblotted with
down assay were detected with fast green staining.were co-transfected with 100 ng/well of the ﬁreﬂy luciferase plasmid,
5 ng/well of pRL-SV40, 200 ng/well of pri-let-7a, and 500 ng/well of
Lin28 or the indicated Lin28 mutant plasmids using the VigoFect reagent
(Vigofect). Luciferase activitywasdeterminedusing theDual-LuciferaseRe-
porter system (Promega). Fireﬂy luciferase activity levels were normalized
against renilla luciferase activity for transfection efﬁciency correction. The
luciferase assay was performed at least three times.
3. Results
3.1. Lin28 interacts with PCAF
Weﬁrst transfected a PCAF expression construct intoHEK293T cells to
assay any effect on Lin28 expression in these cells. To our surprise, the
Lin28protein levelwas signiﬁcantly reduced, decreasing to 45%of its orig-
inal level in the presence of PCAF (Fig. 1A). In co-immunoprecipitationere transfectedwith (+) the indicated constructs.Western blot shows the protein levels of
ading control. Relative intensity of the FLAG-Lin28 bands normalized to their correspond-
three independent experiments. (B) Co-IP of Lin28with PCAF. P19 cells were transfected
th panels. (C and D)GST pull-down assays between Lin28 and PCAF. GST-Lin28 (C) or GST-
) or FLAG-Lin28 (D). The pull-down products were immunoblotted with an anti-FLAG an-
c drawing of the wild-type and truncated GST-tagged Lin28 fragments. The bottom panel
. GST-Lin28 or the GST-Lin28 truncations were incubated with WCEs from HEK293T cells
anti-FLAG antibody. Input: WCE control. The GST-tagged proteins used in the GST pull-
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in the presence of FLAG-Lin28, indicating that PCAF and Lin28
were interacting inHEK293T cells (Fig. 1B, top panel). In a reciprocal ex-
periment, Myc-Lin28 could also be precipitated using anti-FLAG in the
presence of FLAG-PCAF, thereby conﬁrming the interaction between
Lin28 and PCAF (bottom panel). Next, we performed in vitro GST-pull-
down assays using GST-Lin28 and GST-PCAF to pull down FLAG-PCAF
and FLAG-Lin28, respectively, from HEK293T cell lysates (Fig. 1C and
D). Each pull-down product was then immunoblotted using anti-FLAG
antibody, and both reactions conﬁrmed an interaction between Lin28Fig. 2. PCAF acetylates Lin28 in the nucleus. (A) Lin28was acetylated by PCAF inHEK293T cells.
Lin28 acetylation was detected by an anti-acetyl lysine antibody (AcK). The same membrane w
ΔHAT2 in cell lysates were detected with an anti-FLAG antibody. (B) Acetylation of Lin28 in P
FLAG M2 beads; IB: AcK antibody. Then, the anti-FLAG antibody was used to detect total Lin2
cells were co-transfected with FLAG-Lin28 and PCAF, and cell fractions were prepared to det
GAPDH: cytoplasmic marker. CE: cytoplasmic extracts; NE: nuclear extracts. (D and E) PCAF ac
sured in an in vitro acetylation assay and detected using an AcK antibody (D) or by autoﬂuorog
Coomassie brilliant blue staining. (+): the indicated proteins or 3H-Ac-CoA added; (++) doub
pressing FLAG-Lin28 and Myc-PCAF. Red, Lin28 immunostained with anti-FLAG antibody; gree
Bar scale: 10 μm. (G andH)mtLin28 exhibited high acetylation levels in both P19 (G) and HEK2
cells. IP: anti-FLAG M2 beads. IB: anti-acetyl lysine for acetylated mtLin28; anti-FLAG for FLAGand PCAF (Fig. 1C and D). To identify the speciﬁc region of Lin28 that
was responsible for the interaction with PCAF, GST expression con-
structs were generated using wild-type Lin28 and 7 individually trun-
cated Lin28 fragments. Each of the expression products was incubated
in vitro with WCEs from HEK293T cells transfected with FLAG-PCAF,
as shown in the top panel (Fig. 1E). Our results implicated the CSD as
the major region responsible for the Lin28/PCAF interaction, while the
basic linker region (BLR) was less effective (Fig. 1E, L3 vs CCHC),
which suggested that the BLR participates in the interaction of the
CCHC with PCAF.HEK293T cells were transfectedwith (+) the indicated constructs. IP: anti-FLAGM2 beads.
as then stripped and reblotted with an anti-FLAG antibody. FLAG-PCAF and FLAG-PCAF-
19 cells. Cells were transfected with (+) the indicated Myc-PCAF or FLAG-Lin28. IP: anti-
8 protein in the IP products or WCEs. (C) The distribution of acetylated Lin28. HEK293T
ect the distribution of acetylated Lin28 with an AcK antibody. Lamin B: nuclear marker;
etylated Lin28 in vitro. The acetylation of GST or GST-Lin28 by GST-PCAF-HAT2 was mea-
raphy (E). Total GST, GST-Lin28 or GST-PCAF-HAT2 was detected by fast green staining or
le dosage of the proteins added. (F) Immunoﬂuorescence on HEK293T cells ectopically ex-
n, PCAF immunostained with anti-Myc antibody. Nuclei were visualized by DAPI staining.
93T cells (H). FLAG-mtLin28 or empty vector was ectopically expressed in P19 or HEK293T
-mtLin28 protein.
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To determinewhether Lin28 is acetylated by PCAF,we performed co-
immunoprecipitation assays in which HEK293T cells were transfected
with Lin28 expression constructs in combination with either wild-type
PCAF or a negative-control mutant lacking the HAT domain (PCAF-
ΔHAT2). An initial blot using a pan-acetyl lysine antibody (AcK) re-
vealed a robust band speciﬁcally corresponding to Lin28, as indicated
by further anti-Lin28 antibody blotting. This band was observed only
in the presence of wild-type PCAF and not with the mutant lacking the
acetyltransferase-domain (Fig. 2A). FLAG-Lin28 was also acetylated in
FLAG-Lin28 and PCAF co-transfected P19 cells (Fig. 2B), and the accumu-
lation of acetylated Lin28 was found to be higher in the nucleus than in
the cytoplasm, as indicated by western blotting (Fig. 2C). Furthermore,
we found that a truncated fragment of PCAF containing only the
HAT2-domain (GST-HAT2) was sufﬁcient to acetylate GST-Lin28 in an
in vitro acetyltransferase assay (Fig. 2D); a tritium-labeled Lin28 band
could be observed via autoﬂuorography, indicating that Lin28 was acet-
ylated by PCAF. However, the GST-HAT2 domain of PCAF also appeared
as an even stronger tritiated band, which suggested the occurrence of
PCAF autoacetylation [17] (Fig. 2E). To further deﬁne the nature of the
Lin28/PCAF interaction, immunoﬂuorescence staining was performed
to determine the cellular localization of these two proteins. Immunoﬂu-
orescence showed that Lin28 was predominantly localized to the
cytoplasm, whereas PCAF was found in the nucleus (Fig. 2F). Lin28 has
been shown to shuttle between the nucleus and cytoplasm [22], which
could explain how PCAF is able to acetylate Lin28 in the nucleus and
how Lin28 can function outside the nucleus in the cytoplasm.
To test whether Lin28 is acetylated by PCAF in the nucleus, we
followed the reference to clone a mutant Lin28 construct [6] that the
mutant Lin28 expressed is exclusively retained in the nucleus and des-
ignated asmtLin28.We found thatmtLin28 proteinwas highly acetylat-
ed in both P19 and HEK293T cells even in the absence of PCAF
transfection (Fig. 2G and H). The hyper-acetylation of mtLin28 suggests
that PCAF-mediated acetylation occurs predominantly in the nucleus in
both cells. LC tandem mass spectrometry (MS/MS) was then used to
identify the speciﬁc lysine residues in Lin28 that are acetylated by
PCAF, and the data showed that at least nine lysine residues were acet-
ylated. However, we were unable to demonstrate which individual
lysine residue was acetylated by PCAF in vivo (data not shown).
3.3. Lin28 acetylation can be reversed by SIRT1
Deacetylases are grouped into three families — the class I and II
histone deacetylase (HDAC) families are inhibited by Trichostatin A
(TSA), and the class III sirtuin (SIRT) family is inhibited by nicotinamide
(NAM) [23]. SIRTs, but not HDACs, appear to be important in Lin28
deacetylation, as Lin28 acetylation could be enhanced by treatment
with NAM but not TSA (Fig. 3A). In addition, recombinant GST-Lin28
that had been previously acetylated by PCAF could be deacetylated
in vitro by GST-SIRT1 in an NAD-dependent manner (Fig. 3B). This ﬁnd-
ing was further substantiated by the SIRT1 knockdown experiments,
wherein shSIRT1-mediated SIRT1 depletion led to signiﬁcantly en-
hanced levels of acetylated Lin28 (Fig. 3C). Meanwhile, acetylated
Lin28 levels were decreased in HEK293T cells co-expressing wild-type
SIRT1 but not the deacetylase-deﬁcient H363Y mutant (Fig. 3D). Co-IP
and GST pull-down assays were carried out to determine whether a di-
rect interaction is required for the deacetylation of Lin28 by SIRT1, and
these two proteins were found to associate with one another in cells
and in vitro (Fig. 3E and F). Similar to the PCAF protein, the localization
of SIRT1 was also predominantly restricted to the nucleus, as deter-
mined by immunoﬂuorescence staining (Fig. 3G). To identify the specif-
ic region in which Lin28 mediates the interaction with SIRT1, GST-
tagged expression constructs corresponding to truncated Lin28
fragments were used to perform GST pull-down assays, as described
above. The in vitro results showed that in addition to the major role ofthe CSD domain, the BLR-containing a CCHC fragmentwas also involved
in the Lin28/SIRT1 interaction (Fig. 3H). To determine whether the
SIRT1-induced deacetylation of Lin28 also occurs in the nucleus, we
again used the nuclear-localized mtLin28 described above and in
Ref. [6]. We found that the level of acetylated mtLin28 in the nucleus
was markedly decreased upon the overexpression of wild-type SIRT1
but not the dominant-negative H363Y construct (Fig. 3J). We further
found that mtLin28 was co-localized with either PCAF or SIRT1 in the
nucleus (Fig. 3K).
3.4. PCAF-mediated acetylation decreases Lin28 stability and enhances
let-7a maturation
To determine the major functional role of PCAF-induced Lin28 acet-
ylation in human cells, a wild-type PCAF expression construct was co-
transfected into HEK293T cells along with FLAG-Lin28. We found that
although PCAF expression induced a marked increase in Lin28 acetyla-
tion (Fig. 2A), the Lin28 protein levels decreased by 55% in the presence
of PCAF andwere reduced even furtherwhen SIRT1 activitywas blocked
by NAM treatment (Fig. 4A). Because PCAF can also function as a tran-
scription factor [24], qRT-PCRwas performed to exclude any possible ef-
fect of PCAF on Lin28 gene expression. However, we observed no
apparent changes in the Lin28 mRNA levels in cells that were either
transfected with PCAF or treated with NAM (Fig. 4B).
Next, the protein biosynthesis inhibitor cycloheximide (CHX) was
used to treat HEK293T cells and monitor the accumulation of the
Lin28 protein. The cells were divided into three groups and transfected
with either FLAG-Lin28 alone (Fig. 4C, lanes 1–3) or FLAG-Lin28 plus
Myc-PCAF (lanes 4–9). Half of the cells (lanes 7–9) were further treated
with NAM as indicated at the top of the ﬁgure. Western blot assays
showed that Lin28 protein levels declined in the presence of PCAF and
added NAM treatment (Fig. 4C, lanes 1 N 4 N 7). CHX treatment for 24
or 48 h did not obviously abrogate Lin28, as shown in lanes 2 & 3 and
5 & 6, whereas Lin28 declined further when PCAF and NAMwere com-
bined with a 48 hour CHX treatment (Fig. 4C, lane 9). Furthermore,
treatment of the co-transfected cells with the proteasome inhibitor
MG132 indicated that the proteasome was not directly involved in re-
ducing the level of Lin28 (Fig. 4D). These results suggested that the
PCAF-induced acetylation of Lin28 was the major factor responsible
for destabilizing Lin28.
Alternatively, it is likely that Lin28 is dually regulated by PCAF in
mammalian cells, with increased acetylation occurring on the one
hand and subsequently decreased protein levels on the other.
Lin28 forms a cytoplasmic complex with pre-let-7 that protects pre-
let-7 from being cleavaged by Dicer into mature let-7; the Lin28–pre-
let-7 complex could also recruit Zcchc11/TUT4 to catalyze a nuclease
activity and promote the degradation of pre-let-7 [8]. Because both of
these Lin28-mediated pathways in the cytoplasm could result in less
mature let-7,we designed an experiment to determine the levels ofma-
ture let-7a and its precursors (pri-let-7a and pre-let-7a) with respect to
the functional state of Lin28 in the presence of either wild-type PCAF or
a mutant PCAF (ΔHAT2) in HEK293T cells.
We demonstrated that the pri-let-7a was processed efﬁciently and
turned into pre-let-7a in the cytoplasm. Pre-let-7a, in the absence of
Lin28, was further processed to become the mature form of let-7a. In
contrast, co-expression of Lin28 in the cytoplasm blocked the process-
ing or cleavage of pre-let-7a, and this could be partially reversed by
co-transfecting Lin28 alongwith wild-type PCAF but not the ΔHATmu-
tant (Fig. 4E). We then performed a luciferase assay in which reporter
activity is suppressed by the binding of mature let-7a to a site in the
3′-UTR of the reporter gene. Luciferase activity was then detected
based on the formation of mature let-7a from pri-let-7a-1 in HEK293T
cells co-transfected with wild-type Lin28, mtLin28, Lin28 containing 6
K/A mutations in the CSD domain, or Lin28 containing 8 K/A mutations
in the CCHC and BLR domains. The let-7a-dependent reporter expres-
sion data showed that, whereas luciferase activity was kept at a high
Fig. 3. Acetylated Lin28 can be deacetylated via direct interaction with SIRT1. (A) Effects of nicotinamide (NAM) and trichostatin A (TSA) on Lin28 acetylation. HEK293T cells transfected
with the indicated constructs were treated with TSA, NAM, or both for 16 h. Acetylation levels of Lin28 were detected using an AcK antibody and an anti-Lin28 antibody for total Lin28.
(B) Deacetylation of acetylated GST-Lin28 by GST-SIRT1 in vitro. (+) or (−): the presence or absence of an indicated protein(s) or reagent(s) in the incubationmedium. Lin28 acetylation
was detected as in 2A. (C) Effect of SIRT1 knock-down on Lin28 acetylation. FLAG-Lin28 and PCAF were co-transfected into HEK293T cells along with shSIRT1 or a non-speciﬁc control
shGFP. Lin28 acetylation levels were detected. (D) Effect of SIRT1 overexpression on Lin28 acetylation. FLAG-Lin28 and PCAF were co-transfected with SIRT1 or SIRT1H363Y and the
Lin28 acetylation levels were detected. (E) Co-IP of Lin28 with SIRT1. Cells were transfected with (+) the indicated constructs. IP: anti-FLAG M2 beads, IB: antibodies against Myc or
FLAG. (F) GST-pull down assayswere carried out to detect the interaction of Lin28with SIRT1. GST or GST-Lin28was incubatedwith cell lysates fromHEK293T cells ectopically expressing
FLAG-SIRT1. The pull-down products were immunoblotted with an anti-FLAG antibody. (G) Immunoﬂuorescence on HEK293T cells ectopically expressing FLAG-Lin28 and Myc-SIRT1.
Red, Lin28 immunostained with an anti-FLAG antibody; green, SIRT1 immunostained with an anti-Myc antibody. Nuclei were visualized by DAPI staining. Bar scale: 10 μm. (H) GST
pull-down assays to detect the interaction of SIRT1with truncated GST-tagged Lin28 fragments. GST or GST-Lin28 truncationswere ﬁrst incubatedwithWCEs of HEK293T cells ectopically
expressing Myc-SIRT1. The GST pull-down products were immunoblotted with an anti-Myc antibody. (J) SIRT1 deacetylated mtLin28. FLAG-mtLin28 was co-transfected with SIRT1 or
SIRT1H363Y in HEK293T cells, and the mtLin28 acetylation levels were detected. (K) mtLin28 colocalized with PCAF and SIRT1 in the nucleus. FLAG-mtLin28 was co-transfected with
Myc-PCAF or Myc-SIRT1 in HEK293T cells and immunoﬂuorescence was performed. Red, mtLin28 immunostained with anti-FLAG antibody; green, SIRT1 or PCAF immunostained with
anti-Myc antibody. Nuclei were visualized by DAPI staining. Bar scale: 10 μm.
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luciferase activity in cells expressing Lin28 with K/A mutations in the
CCHC domain was signiﬁcantly reduced to a level similar to the
mtLin28 that lacks RNA-binding ability [6] (Fig. 4F). Thus, we suggest
that the lysine residues in the CSD are critical for Lin28 to interact
with and be acetylated by PCAF, thereby eliciting Lin28 instability and
further enhancing let-7a maturation in human cells.
4. Discussion
Lin28 activity is precisely regulated during normal development.
During ES cell differentiation, Lin28 is regulated by multiple different
mechanisms. For example, Lin28 is down-regulated at the post-
transcriptional level viamiR-125b in retinoic acid-induced P19 embry-
onic carcinoma cells [25] and at the transcriptional level in the TERA-2EC cells [26]. Although Lin28 has been implicated in development, the
induction of stem cell pluripotency, and tumor progression [14], the de-
tailed mechanisms underlying the regulation of Lin28 protein stability
are not fully understood.
Several lines of evidence suggest an important role for acetylation in
regulating protein stability, such as enhanced E2F1 protein stability [27]
or increased degradation of hypoxia-inducible factor 1 (HIF-1) [28].
Consistent with the ﬁndings for HIF-1, the PCAF-mediated acetylation
of Lin28 was found to signiﬁcantly decrease Lin28 protein stability in
the present study. The acetylation of lysine residues in the CSD was
the most important in this process because the Lin28 protein would
otherwise be unresponsive to PCAF treatment and let-7a biogenesis
would remain blocked.
It has been reported that the acetyltransferase PCAF and the
deacetylase SIRT1 have common targets, including MyoD [29] and
Fig. 4.PCAF-mediated acetylation decreases the stability of Lin28. (A) Impact of PCAF overexpression andNAM treatment on Lin28 protein levels. HEK293T cells transfectedor treatedwith
(+) the indicated constructs or NAM. The protein levels of Lin28 and PCAF were detected with an anti-FLAG and anti-Myc antibody, respectively. GAPDH: loading control. The relative
intensity of the FLAG-Lin28 bands is shown in the bottom panel. Each bar represents the mean value ± S.D. from at least three independent experiments. (B) Effect of PCAF on Lin28
mRNA levels. HEK293T cells transfected with the indicated constructs (+) were harvested for qRT-PCR. Each bar represented the mean value ± S.D. from at least three independent ex-
periments. (C) Impact of PCAF-mediated acetylation on Lin28protein stability. HEK293T cellswere transfectedwith the indicated constructs or treatedwithNAM(+) and 30 h after trans-
fection, cells were further treated with cycloheximide (CHX) for the length of incubation as indicated. Lin28 protein levels were analyzed by western blot. (D) Impact of proteasome
inhibitor MG132 on Lin28 protein levels in the presence of PCAF. FLAG-Lin28 was co-transfected with PCAF in HEK293T cells for 30 h, and the cells were treated with or without
25 μMMG132 for 8 h. Lin28 protein levels were analyzed by western blot. The relative intensity of the FLAG-Lin28 bands was detected and normalized to their corresponding loading
controls and shown in the bottom of each lane. (E) Quantitative RT-PCR showing changes in levels of pri-let-7a, pre-let-7a and mature let-7a upon co-expression with FLAG-Lin28 and
PCAF in HEK293T cells. Each bar represents the mean value ± S.D. from at least three independent experiments. Statistical analysis was performed using a two-tailed Student's t-test.
Probabilities of P b 0.05 were considered signiﬁcant (*). (F) Relative luciferase activity from a ﬁreﬂy luciferase gene containing a binding site for let-7a in the 3′UTR was measured in
HEK293T cells co-transfected with pri-let-7a and the indicated Lin28 (wild-type or mutant) expression plasmids. The signal from the ﬁreﬂy luciferase was normalized with that from
renilla luciferase. Each bar represents the mean value ± S.D. from at least three independent experiments.
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for PCAF-mediated acetylation but also for SIRT-mediated deacetylation
and that a balance between the activities of PCAF and SIRT1 determines
the level of Lin28 acetylation in human cells. How can Lin28, a mostly
cytoplasmic protein, be acetylated by PCAF and deacetylated by SIRT1,
both of which are located in the nucleus? This discrepancy can be ex-
plained by the shuttling of Lin28 in and out the nucleus [6]. As an excep-
tion, a Lin28 mutant without RNA-binding ability is located exclusively
in the nucleus [6], and this nuclear Lin28 mutant exhibits high levels of
acetylation evenwithout the co-expression of PCAF. Acetylation renders
Lin28 susceptible to protein degradation and reduces Lin28 to a signiﬁ-
cantly low level in cells that is insufﬁcient for any of its biological
functions.
SIRT1 is an important regulator involved in metabolism, differentia-
tion, cancer, stress responses and cell senescence [34]. Notably, SIRT1
plays a major role in reprogramming mouse embryonic ﬁbroblasts
(MEFs) into iPS cells [35], and Lin28 is one of several critical factors
that are required to generate iPS cells [4]. SIRT1 was highly efﬁcient at
reversing the acetylation of Lin28 in our study, which raises the ques-
tion of whether SIRT1 could impact the reprogramming of iPS cells via
the stability of Lin28. Additionally, Sox2 was reported to be negatively
regulated by acetylation in ES cells [3636]; therefore, we wonder
whether Lin28 could also be affected by acetylation in these cells.
Further work would be needed to clarify this issue, which would also
signiﬁcantly enhance our understanding of the molecular mechanisms
responsible for controlling the pluripotency of ES cells.
In summary, we have identiﬁed a novel mechanism for the regula-
tion of Lin28 in let-7a biogenesis in human cells. The regulation of
pre-let-7a processing depends on the stability of Lin28, which isdetermined by its acetylation by PCAF and deacetylation by SIRT1.
These ﬁndings regarding the modiﬁcation and regulation of Lin28 are
applicable to our knowledge of Lin28 regulation in ES cells and shed
light on potential applications for the development of novel techniques
for efﬁciently generating iPS cells.
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